Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × iberdomide × Clear all

Phase

Phase 2 5 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 3 1

Status

Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 111 Cisplatin 100 Paclitaxel 81 pembrolizumab 74 Gemcitabine 59 Cyclophosphamide 53 Pemetrexed 47 durvalumab 46 Dexamethasone 46 Docetaxel 45 Capecitabine 44 Radiotherapy 43 Doxorubicin 43 Nivolumab 38 Lenalidomide 37 Vincristine 36 Specimen Handling 36 Etoposide 35 Rituximab 34 Magnetic Resonance Spectroscopy 33 Oxaliplatin 32 Bevacizumab 32 atezolizumab 31 Fluorouracil 30 Radiation 28 Prednisone 26 Leucovorin 26 Bortezomib 26 Fulvestrant 23 Letrozole 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04975997 2026-04-03

EXCALIBER-RRMM

Celgene

Phase 3 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡